Original Investigation
Risk of Major Adverse Cardiovascular Events Following Nicotinamide Exposure
Lee Wheless, MD, PhD; Ranya Guennoun, BS; Basia Michalski-McNeely, MD; et al.
Brief Report
Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1 With MEK Inhibitor Selumetinib: A Nonrandomized Clinical Trial
Andrea M. Gross, MD; Olivia H. Reid, BS; Lauren A. Baldwin, BS; et al.
Validation of DermSat-7 for Assessing Treatment Satisfaction in Patients With Psoriasis
April W. Armstrong, MD, MPH; Kathryn Lee, MD; Danielle Yee, MD; et al.
Research Letter
Patterns and Clinical Implications of Misdiagnosis in Dermatomyositis
Aaron Bao, BA; Saloni Patel, BS; Christopher A. Mecoli, MD, MHS; et al.
Observation
Tofacitinib for Treatment of Acquired Reactive Perforating Collagenosis
Ruiqing Yuan, MBBS; Guizhi Zhou, MD; Hong Liu, MD, PhD
From JAMA This Week
Reaffirming the JAMA Network Commitment to the Health of Patients and the Public
Kirsten Bibbins-Domingo, PhD, MD, MAS; Robert O. Bonow, MD, MS; Neil M. Bressler, MD; et al
Correction
Errors in the Supplement
|